145 related articles for article (PubMed ID: 26064686)
21. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.
Stefancin P; Govindarajan ST; Krupp L; Charvet L; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():101-105. PubMed ID: 30954931
[TBL] [Abstract][Full Text] [Related]
22. [Information processing speed and influential factors in multiple sclerosis].
Zhang ML; Xu EH; Dong HQ; Zhang JW
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
[TBL] [Abstract][Full Text] [Related]
23. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
[TBL] [Abstract][Full Text] [Related]
24. New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study.
Wybrecht D; Reuter F; Pariollaud F; Zaaraoui W; Le Troter A; Rico A; Confort-Gouny S; Soulier E; Guye M; Maarouf A; Ranjeva JP; Pelletier J; Audoin B
PLoS One; 2017; 12(11):e0184650. PubMed ID: 29149177
[TBL] [Abstract][Full Text] [Related]
25. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
26. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
[TBL] [Abstract][Full Text] [Related]
27. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
[TBL] [Abstract][Full Text] [Related]
28. The Role of Information Processing Speed in Clinical and Social Support Variables of Patients with Multiple Sclerosis.
Eizaguirre MB; Vanotti S; Merino Á; Yastremiz C; Silva B; Alonso R; Garcea O
J Clin Neurol; 2018 Oct; 14(4):472-477. PubMed ID: 30198225
[TBL] [Abstract][Full Text] [Related]
29. Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
van Gorp DAM; van der Hiele K; Heerings MAP; Jongen PJ; van der Klink JJL; Reneman MF; Arnoldus EPJ; Beenakker EAC; van Eijk JJJ; Frequin STFM; de Gans K; Hoitsma E; Mostert JP; Verhagen WIM; Zemel D; Visser LH; Middelkoop HAM
Neurol Sci; 2019 Dec; 40(12):2555-2564. PubMed ID: 31321625
[TBL] [Abstract][Full Text] [Related]
30. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
[TBL] [Abstract][Full Text] [Related]
31. Indices of cognitive dysfunction in relapsing-remitting multiple sclerosis: intra-individual variability, processing speed, and attention network efficiency.
Wojtowicz M; Omisade A; Fisk JD
J Int Neuropsychol Soc; 2013 May; 19(5):551-8. PubMed ID: 23425598
[TBL] [Abstract][Full Text] [Related]
32. Fatigue during multiple sclerosis relapse and its relationship to depression and neurological disability.
Šabanagić-Hajrić S; Suljić E; Kučukalić A
Psychiatr Danub; 2015 Dec; 27(4):406-12. PubMed ID: 26609654
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed.
Sandroff BM; Hillman CH; Benedict RH; Motl RW
J Clin Exp Neuropsychol; 2015; 37(2):209-19. PubMed ID: 25658772
[TBL] [Abstract][Full Text] [Related]
34. A novel cognitive-behavioral stress management method for multiple sclerosis. A brief report of an observational study.
Anagnostouli M; Babili I; Chrousos G; Artemiadis A; Darviri C
Neurol Res; 2019 Mar; 41(3):223-226. PubMed ID: 30451648
[TBL] [Abstract][Full Text] [Related]
35. What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
Kluckow SW; Rehbein JG; Schwab M; Witte OW; Bublak P
Cortex; 2016 Oct; 83():167-80. PubMed ID: 27552137
[TBL] [Abstract][Full Text] [Related]
36. Employment and absenteeism in working-age persons with multiple sclerosis.
Salter A; Thomas N; Tyry T; Cutter G; Marrie RA
J Med Econ; 2017 May; 20(5):493-502. PubMed ID: 28035846
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
[TBL] [Abstract][Full Text] [Related]
38. Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis.
Wojtowicz MA; Ishigami Y; Mazerolle EL; Fisk JD
J Clin Exp Neuropsychol; 2014; 36(5):455-63. PubMed ID: 24742170
[TBL] [Abstract][Full Text] [Related]
39. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
Bergendal G; Fredrikson S; Almkvist O
Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
[TBL] [Abstract][Full Text] [Related]
40. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
